Blueprint Medicines (BPMC) – Hot FDA News
-
Blueprint Medicines (BPMC) says FDA lifts partial clinical hold on BLU-222
-
Blueprint Medicines (BPMC) Announces Partial Clinical Hold for Phase 1/2 VELA Trial of BLU-222
-
-
-
-
-
-
-
-
-
-
-
Back to BPMC Stock Lookup